Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants

Pediatr Pulmonol. 2024 Apr 12. doi: 10.1002/ppul.26997. Online ahead of print.

Authors

Emily Mitchell¹, Dana Albon¹

Affiliation

¹ Department of Pulmonology, University of Virginia, Charlottesville, Virginia, USA.

PMID: 38607232
DOI: 10.1002/ppul.26997

No abstract available

Keywords: conductance regulator modulators; conductance regulator‐CFTR; cystic fibrosis transmembrane; cystic fibrosis‐CF.

Grants and funding

None